Search

Search Results
Results 1401 - 1410 of 1412 for chronic pain syndrome
  • Lenest 30 ED
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Lenest 30 ED intended for persons living in Australia.
  • Norimin
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin intended for persons living in Australia.
  • Norimin-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin-1 intended for persons living in Australia.
  • Tenofovir Disoproxil Viatris
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Viatris (tenofovir disoproxil maleate 300 mg) intended for persons living in Australia.
  • Bisolvon Chesty Forte Tablets
    Drug - 6 May 2022
    Consumer Medicine Information (CMI) about Bisolvon Chesty Forte Tablets intended for persons living in Australia.
  • Flagyl S
    Drug - 5 Apr 2022
    Consumer Medicine Information (CMI) about Flagyl S intended for persons living in Australia.
  • Flagyl
    Drug - 29 Mar 2022
    Consumer Medicine Information (CMI) about Flagyl intended for persons living in Australia.
  • Clopixol
    Drug - 28 Mar 2022
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Bisolvon Chesty Kids Strawberry Oral Liquid
    Drug - 1 Jul 2021
    Consumer Medicine Information (CMI) about Bisolvon Chesty Kids Strawberry Oral Liquid intended for persons living in Australia.
  • Bisolvon Chesty Forte Oral Liquid
    Drug - 1 Jul 2021
    Consumer Medicine Information (CMI) about Bisolvon Chesty Forte Oral Liquid intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback